Personalized Care with DPP4i/SGLT2i Strategy as Initial-Line in the Management of Type 2 Diabetes Mellitus with Cardiovascular Risk: DELPHI Statement. ccm. 2024;8(2):111-117. Accessed September 17, 2026. https://fortunejournals.org/ojs/index.php/ccm/article/view/16470